The current status of interferon‐α treatment in advanced renal cancer
作者： J. Stebbing , M. Gore
DOI: 10.1046/J.1464-410X.2001.02140.X
关键词: Kidney 、 Oncology 、 Interferon α 、 Immunotherapy 、 Toxicity 、 Internal medicine 、 Medicine 、 Interferon alfa 、 Alpha interferon 、 Cancer 、 Kidney disease 、 Immunology
摘要:
sci-hub.se 参考文章(19)
Ritchie Aw, deKernion Jb, The natural history and clinical features of renal carcinoma. Seminars in Nephrology. ,vol. 7, pp. 131- ,(1987)
Donald L. Trump, Robert S. Witte, Paul J. Elson, Prognostic Factors for Survival in Patients with Recurrent or Metastatic Renal Cell Carcinoma Cancer Research. ,vol. 48, pp. 7310- 7313 ,(1988)
Chris Coppin, Franz Porzsolt, Michael Autenrieth, Julia Kumpf, Andrew Coldman, Timothy Wilt, Immunotherapy for advanced renal cell cancer Cochrane Database of Systematic Reviews. ,vol. 2015, ,(2015) , 10.1002/14651858.CD001425.PUB2
Robert J. Motzer, Barbara A. Murphy, Jennifer Bacik, Lawrence H. Schwartz, David M. Nanus, Tania Mariani, Patrick Loehrer, George Wilding, Diane L. Fairclough, David Cella, Madhu Mazumdar, Phase III Trial of Interferon Alfa-2a With or Without 13-cis-Retinoic Acid for Patients With Advanced Renal Cell Carcinoma Journal of Clinical Oncology. ,vol. 18, pp. 2972- 2980 ,(2000) , 10.1200/JCO.2000.18.16.2972
Seppo Pyrhönen, Eeva Salminen, Mirja Ruutu, Timo Lehtonen, Martti Nurmi, Teuvo Tammela, Harri Juusela, Erkki Rintala, Päivi Hietanen, Pirko-Liisa Kellokumpu-Lehtinen, Prospective Randomized Trial of Interferon Alfa-2a Plus Vinblastine Versus Vinblastine Alone in Patients With Advanced Renal Cell Cancer Journal of Clinical Oncology. ,vol. 17, pp. 2859- 2859 ,(1999) , 10.1200/JCO.1999.17.9.2859
G. Steineck, H. Strander, B.-E. Carbin, E. Borgström, L. Wallin, U. Achtnich, A. Arvidsson, V. Söderlund, I. Naslund, P.-L. Esposti, S. E. Norell, Recombinant leukocyte interferon alpha-2a and medroxyprogesterone in advanced renal cell carcinoma. A randomized trial. Acta Oncologica. ,vol. 29, pp. 155- 162 ,(1990) , 10.3109/02841869009126537
B.W. Hancock, S. Harris, K. Wheatley, M. Gore, Adjuvant interferon-alpha in malignant melanoma: current status☆ Cancer Treatment Reviews. ,vol. 26, pp. 81- 89 ,(2000) , 10.1053/CTRV.1999.0163
M. Kriegmair, R. Oberneder, A. Hofstetter, Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma Urology. ,vol. 45, pp. 758- 762 ,(1995) , 10.1016/S0090-4295(99)80079-X
T Eisen, C Boshoff, I Mak, F Sapunar, M M Vaughan, L Pyle, S R D Johnston, R Ahern, I E Smith, M E Gore, Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer. British Journal of Cancer. ,vol. 82, pp. 812- 817 ,(2000) , 10.1054/BJOC.1999.1004
S. FOSSA, M. JONES, P. JOHNSON, J. JOFFE, E. HOLDENER, P. ELSON, A. RITCHIE, P. SELBY, Interferon-alpha and survival in renal cell cancer. BJUI. ,vol. 76, pp. 286- 290 ,(1995) , 10.1111/J.1464-410X.1995.TB07702.X